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Abstract 
Objective 
Brain Age Index (BAI), calculated from sleep electroencephalography (EEG), has been proposed as a 
biomarker of brain health. This study quantifies night-to-night variability of BAI and establishes 
probability thresholds for inferring underlying brain pathology based on a patient’s BAI. 
 
Methods 
86 patients with multiple nights of consecutive EEG recordings were selected from Epilepsy Monitoring 
Unit patients whose EEGs reported as being within normal limits. BAI was calculated for each 12-hour 
segment of patient data using a previously described algorithm, and night-to-night variability in BAI was 
measured.  
 
Results 
The within-patient night-to-night standard deviation in BAI was 7.5 years. Estimates of BAI derived by 
averaging over 2, 3, and 4 nights had standard deviations of 4.7, 3.7, and 3.0 years, respectively. 
 
Conclusions 
Averaging BAI over 𝑛 nights reduces night-to-night variability of BAI by a factor of √𝑛, rendering BAI 
more suitable as a biomarker of brain health at the individual level. 
 
Significance 
With increasing ease of EEG acquisition including wearable technology, BAI has the potential to track 
brain health and detect deviations from normal physiologic function. In a clinical setting, BAI could be 
used to identify patients who should undergo further investigation or monitoring. 
 
Keywords: Brain Age, EEG, Sleep, Brain Age Variability 
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1. Introduction 
There are several dimensions of measurable brain health, including subjective complaints, 
neuropsychological testing (Lezak 2012), cerebral oxygen extraction and blood flow (Xu et al. 2009), 
brain structure using magnetic resonance imaging (Carne et al. 2006), and electroencephalographic (EEG) 
markers (Al Zoubi et al. 2018). The latter may be measured during wake or sleep. Wake characteristics of 
abnormal brain function include pathological slowing and abnormalities of alpha wave frequency and 
distribution. Sleep markers of brain health include spindle and delta power and K-complexes 
characteristics, which reflect health of the < 1 Hz non-rapid eye movement (NREM) sleep slow oscillation 
(Urakami et al. 2012). However, in isolation these biomarkers have shown only weak associations with 
disease state, and only at the group level.  
The brain age index (BAI) is an algorithm for measuring how much an individual’s 
electroencephalographic (EEG) brain activity during sleep differs from the expected pattern for an 
individual’s age, based on a large number of features extracted from different sleep stages and the 
awake state. BAI is derived by first producing an estimate of the individual’s age from an overnight sleep 
EEG, called the brain age (BA), and subtracting from this the individual’s chronologic age (CA). Prior 
research suggests that, at the population level, brain age correlates strongly with chronologic age, and  
excess brain age (BAI>0) is associated with conditions that worsen brain function (e.g., diabetes, 
hypertension, dementia, psychiatric disease) (Sun et al. 2019). Thus, BAI holds promise as a biomarker of 
brain health.   
However, before BAI can be applied in individual patients, it is necessary to understand its night-to-night 
variability, or its converse, night-to-night stability. Nightly variation in sleep EEG patterns may arise from 
either short-term factors not strongly related to long-term brain health, such as light or noise, body 
position, recent sleep loss, or other sleep disturbances (Brunner et al. 1993). By contrast, “brain health”, 
as influenced by long-term exposure to factors such as cerebrovascular or neurogenerative disease, 
chronic intermittent hypoxia from sleep apnea, inflammatory states, exercise, nutrition, or long-term 
sleep habits, is expected to vary more slowly, perhaps over the course of weeks to months or even years, 
but to be relatively stable on a night-to-night time scale. If BAI shows high night-to-night variability, then 
it may be advantageous to measure BAI several nights in a row and average the measurements, to 
derive a meaningful biomarker of brain health more applicable at the level of individuals. By this 
reasoning, the degree to which a high BAI value should be considered “abnormal” depends on the 
extent to which it exceeds expected levels of night-to-night fluctuation.  
In this study, we therefore aimed to: (1) determine the night-to-night variability of the brain-age index in 
individual patients, and (2) establish thresholds for the probability of underlying brain pathology based 
on a patient’s BAI, i.e. values of BAI above which concern and further investigation are warranted.  
 
2. Methods 
2.1. Patient Selection Criteria 
For this study, we obtained data from adult patients who underwent multi-day EEG recordings during 
the course of routine clinical care but were not acutely ill. The Epilepsy Monitoring Unit (EMU) provides 
such a cohort.  Patients admitted to the EMU include a mixture of those with established epilepsy 
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(excluded from the present study), and those being evaluated to determine whether or not they have 
epilepsy. A portion of patients in the latter group ultimately prove to have normal EEGs; some of these 
are patients with epilepsy whose burden of seizures and epileptiform activity is low, while others are 
ultimately found to have problems unrelated to epilepsy (e.g., behavioral / psychogenic events or 
cardiac events masquerading as seizures). EEG data from these patients provide a unique opportunity to 
use existing clinical data to estimate night-to-night variability of EEG-based brain age in EEGs that are 
free of epileptiform abnormalities which would otherwise interfere with calculation of BAI. 
We therefore used the following criteria to select patient data for our present study: eligible subjects 
included any adult patient (≥18 years) who underwent continuous EEG (cEEG) monitoring at the 
Massachusetts General Hospital Epilepsy Monitoring Unit (EMU) between May 1, 2014, and May 1, 2019, 
who had (1) at least two consecutive nights of EEG recordings;  (2) the EEG recordings were “normal” 
(i.e., showed no signs of epileptiform EEG activity, as such abnormalities would affect the calculation of 
brain age) as determined by the clinical report signed by the attending clinical neurophysiologist; and (3) 
at least five hours of cEEG data for each 12-hour period. EEG outside of sleep times was not considered 
in this analysis. Five hours was chosen because it typically suffices to sample multiple epochs of each 
stage of sleep. 
While no EEGs containing epileptiform activity were included, some patients had a diagnosis of epilepsy. 
Out of 1,147 patients admitted to the EMU during the 5-year period, eighty-six patients met the 
inclusion criteria. A patient selection flowchart is shown in Figure 1.  
The Partners Institutional Review Board approved this retrospective analysis without requiring 
additional consent for its use in this study. 
 
Figure 1- Patient Selection Flowchart. 
 
2.2. Patient Cohort 
Previous MRI studies show that epileptic patients’ brains appear to show structural signs of accelerated 
biological aging (Pardoe et al. 2017; Sone et al. 2019). To test whether this observation also applies to 
BAI, we examined whether BAI differs in patients with vs without epilepsy. For this comparison we used 
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a one-sided, two-sample Welch’s t-test, with the hypothesis that epileptic patients would have a higher 
average BAI than those without epilepsy. 
In addition, we examined the difference in within-patient standard deviation in BAI between epileptic 
patients and non-epileptic patients using a two-sided, two-sample t-test. This was done to verify our 
assumption that the standard deviation in BAI estimates does not vary significantly between the two 
groups. 
2.3. EEG Preprocessing and Artifact Removal 
Our study used 6 channels for sleep-staging: frontal (F3 and F4), central (C3 and C4), and occipital (O1 
and O2). The EEG signals were notch-filtered at 60Hz and then bandpass filtered from 0.5 – 20Hz. EEG 
signals were divided into 30-second epochs for analysis. Each 30-second epoch was marked as artifact 
and removed if the epoch contained two or more seconds of saturated signal (amplitude greater than 
500µV), or five or more seconds of flat EEG signal (standard deviation of the amplitude less than .2 µV 
for five seconds, or less than 1 µV for the whole 30-second epoch). 
2.4. Sleep Staging 
To classify EEG epochs into sleep-stages, a previously published extreme learning machine (ELM) based 
model, trained on a dataset of 2,000 PSGs, was used (Sun et al. 2017). This algorithm classifies each 30-
second EEG epoch into one of five stages: awake, NREM1, NREM2, NREM3, or REM. 
2.5. Removing Eye-open Awake Signals 
The ELM based brain age algorithm was trained on data from patients in a sleep lab setting, consisting 
primarily of eyes-closed, in-bed periods, whereas the EMU EEG data used in the present study also 
includes prolonged periods when patients are active and awake. To render the data appropriate for the 
BAI algorithm, eyes-open awake epochs were removed using an automated process. This process uses a 
customized blink detection algorithm, as follows: After sleep staging, ten randomly-selected, one-
minute awake EEG segments were hand labeled for blinks, and a parameter search was performed to 
optimize a threshold for peak detection (Gramfort et al. 2013, 2014), used in a blink-detection algorithm 
developed by MNE (a signal-processing software suite named for its ability to calculate Minimum Norm 
Current Estimates) (Gramfort et al. 2013). This algorithm first filters the signal using a Finite Impulse 
Response (FIR) and a band pass filter and then detects peaks. We used bipolar montage channels Fp1-F3 
and Fp2-F4 channels in the blink detection routine. MNE source code can be found here (Larson 2019a, 
2019b).The optimal threshold was 90µV, with a Cohen’s kappa value of 0.83.  
To remove eyes-open awake data, 30-second epochs which (1) contained greater than six blinks and (2) 
were classified as awake by the ELM based sleep-staging model were removed. On average, the eyes-
open awake period comprised 15.1% of the data. After removing eyes-open awake epochs, patients 
with at least one epoch containing five hours of usable data were included. The mean number of 
available 5-hour epochs per patient during their EMU stay was 5.6. 
2.6. Brain Age Night-to-Night Variability Analysis 
EEG features and sleep-stages are required inputs for calculating BAI.  Features were calculated using 
previously published methods (Sun et al. 2019). The previous study used frontal (F3-M2 and F4-M1), 
central (C3-M2 and C4-M1) and occipital (O1-M2 and O2-M1), with each channel referenced to the 
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contralateral mastoid. Our study used the same 6 channels: frontal (F3 and F4), central (C3 and C4) and 
occipital (O1 and O2), except that the reference channel was C2 (second cervical vertebra) rather than 
the contralateral mastoid. 
Our goal here was to quantify variability of BAI for a patient that has had 𝑛 close-in-time sleep EEGs 
(spaced apart by no more than a few days), hence 𝑛 BAI estimates. We propose both a “theory” and an 
empirical approach to verify the theory: 
2.6.1. Signal + Noise theory of multi-night BAI variability:  
We hypothesized that BAI measurements taken within a few days of each other can be modeled as a 
constant, the “true” underlying value of the BAI, plus independent noise:  
𝐵𝐴𝐼̂ = 𝐵𝐴𝐼 +  𝜖  (Equation 1) 
We assume that the noise is normally distributed with zero mean, 𝜖~𝑁(0, 𝜎2), where 𝜎2 is the variance, 
to be estimated. Under this simple model, when more than one BAI measurement is available 
𝐵𝐴𝐼̂ 1, 𝐵𝐴𝐼̂ 2, … , 𝐵𝐴𝐼̂ 𝑛, we average the measurements to obtain an estimate with a higher signal to noise 
ratio, 〈𝐵𝐴𝐼𝑛〉 =
1
𝑛
∑ 𝐵𝐴𝐼̂ 𝑖
𝑛
𝑖=1 . Under this model, the standard error of the mean 〈𝐵𝐴𝐼𝑛〉 decreases as 
1/√𝑛, thus  
〈𝐵𝐴𝐼𝑛〉 = 𝐵𝐴𝐼 +  𝜖
′, where 𝜖′ ∼ 𝑁 (0,
𝜎2
𝑛
)  (Equation 2).   
Our primary objective is to estimate the standard deviation of BAI measurements, 𝜎. We note that the 
assumption that the data follow a normal distribution is not strictly required for the variance to 
decrease as proposed. Nevertheless, we make this assumption for simplicity and subsequently verify 
that it provides a reasonable empirical fit to the data.  
2.6.2. Empirical approach to multi-night BAI variability:  
We take an empirical approach to verifying the theoretical model previously described. For explanatory 
purposes, we choose an example patient who has 7 independent measurements of BAI from 7 nights of 
EEG data (Figure 2). Since the objective is to characterize how averaging multiple independent BAI 
estimates reduces within-patient standard deviation in BAI, we calculate the within-patient standard 
deviation of BAI measurements that are averaged over 𝑛 nights. For the case where 𝑛 =1, a single BAI 
estimate is computed for each night (no averaging). In cases where 𝑛 is greater than 1, BAI estimates are 
calculated by averaging 𝑛 independent BAI calculations from 𝑛 nights.  
In the case where 𝑛 =1 (no averaging), we calculate the standard deviation in brain age estimates for 
each patient using all available BAI values for each patient. For an example patient with seven nights of 
data, this would simply be the standard deviation of these seven estimates (Figure 2a). 
Next, consider the case where BAI estimates from multiple nights are averaged together to arrive at a 
less noisy BAI estimate. We explain our approach beginning with the case where  𝑛 = 2 (Figure 2b). To 
estimate the standard deviation of averages based on pairs of BAI measurements, we partition each 
patient’s single-night brain age estimates into groups of two. We use the word partition deliberately: to 
ensure that our estimates of variability are not downwardly biased, we do not take all possible pairs of 
two; rather, we allow any single observation to show up in only one pair of measurements. For a patient 
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with seven brain age estimates, we calculate 3 means of BA estimates using 3 pairs: 1-2, 3-4, and 5-6, 
with brain age estimate 7 not used (Figure 2b). The within-patient standard deviation of these pair-
based (𝑛 =2) average BAIs is the standard deviation of these three independent values. Note that we do 
not consider all pairs of size 2 (of which there are 21) because many of those pairs (18 out of 21) would 
have an observation which shows up in at least one other pair, which would cause the mean calculated 
from those 2 pairs to be correlated and bias the estimated variability downward. 
When 𝑛 =3, we partition the sample into groups of 3 independent BAI measurements (Figure 2c). We 
then calculate the average BAI for each of these groups. For our example patient, BAI estimates would 
be separated into two groups—containing estimates 1,2, and 3; and estimates 4,5, and 6—and 
groupwise average BAIs would be calculated. The within-patient standard deviation for this patient 
when 𝑛 =3 is the standard deviation between the two average BAI estimates (Figure 2c). 
For a patient with seven brain age estimates, note that we could not calculate the standard deviation of 
BAI if 𝑛 =4 nights, because there aren’t enough estimates to calculate two independent means of BAI 
which use 4 nights each. Thus, the standard deviation for estimates of brain age obtained by averaging 4 
(or 𝑛) nights is only calculated if patients had at least 8 (2𝑛) nights of EEG data (Figure 2d). 
The stated procedure—partitioning each patient’s brain age estimates into groups of size n, taking the 
average BAI for each group, and calculating the standard deviation of group averages—is repeated 1,000 
times per patient using random permutations, and the average within-patient standard deviation in BAI 
is used for each patient. 
 
Figure 2- Diagram showing how the standard deviation in brain age index was calculated for 𝑛 = 1, 2, 3, 
and 4 nights for a single patient. For 𝑛 = 2-4, each procedure was repeated using 1,000 random 
permutations, and the results were averaged. 
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2.7. Effect of Sleep Stage distribution on BAI Variability 
To understand whether BAI variability is related to the percent of time spent in each sleep stage, we first 
calculate the stage distribution (percent of time spent in each sleep stage) for each patient. Then, a 
regression model is fit, attempting to predict the patient’s standard deviation in BAI from the percent of 
time spent in each stage using both univariate regression for each sleep stage, and multivariate linear 
regression using all sleep stages. 
We also investigate whether BAI variability might be explained in part by night-to-night variability in a 
patient’s sleep stage distribution. To test this possibility, we calculate the standard deviation in the 
percent of time spent in each sleep stage for each patient. Then, another regression model is fit, 
attempting to predict the patient’s standard deviation in BAI from the standard deviation in percent of 
time spent in each stage using both univariate regression for each sleep stage, and multivariate linear 
regression using all sleep stages.  
2.8. Defining Brain Age Risk Lookup Table 
Using the mean intra-patient standard deviation for 𝑛 =1, 2, 3, and 4 nights, we calculate the probability 
that a patient’s true brain age index (the BAI estimate based on an infinite number of nights) would be 
equal to their BAI estimate. Adopting a Bayesian framework, we assume that, conditional on the 
patient’s true BAI, the distribution of brain age estimates (𝐵𝐴𝐼̂ ) is randomly distributed around that true 
BAI, according to Equation 1 (𝐵𝐴𝐼̂ = 𝐵𝐴𝐼 +  𝜖,   𝜖 ∼ 𝑁(0, 𝜎2)). As for the prior distribution over values 
of BAI, we assume it is uniformly distributed on an interval [𝐿, 𝑈]. This choice of prior avoids any strong 
assumptions regarding whether patients undergoing BAI testing are from a healthy vs. sick population, 
in line with our goal of using BAI as a biomarker of brain health across a wide range of patients. Given 
this assumption, we apply Bayes rule to make inferences about a patient’s actual brain age index, 𝐵𝐴𝐼, 
given their brain age estimate, 𝐵𝐴𝐼̂ : 
𝑃(𝐵𝐴𝐼|𝐵𝐴𝐼̂ ) =
𝑃(𝐵𝐴𝐼̂ |𝐵𝐴𝐼)𝑃(𝐵𝐴𝐼)
𝑃(𝐵𝐴𝐼̂ )
  (Equation 2) 
Under the assumption that the distribution of brain age estimates—𝑃(𝐵𝐴𝐼̂ |𝐵𝐴𝐼)—is normally 
distributed around a patient’s true BAI and the true distribution of patient BAIs—𝑃(𝐵𝐴𝐼)—is uniformly 
distributed, the posterior distribution 𝑃(𝐵𝐴𝐼|𝐵𝐴𝐼̂ ) is (approximately) a normal distribution. Thus, the 
probability distribution of a patient’s true BAI is normally distributed around an unbiased estimate of 
BAI. Note that the posterior distribution is technically a truncated normal distribution; however, to 
reflect a lack of strong conviction regarding the true BAI’s distribution, choosing a large interval [𝐿, 𝑈] 
for the uniform distribution approximately results in a normal distribution. 
Using the normal distribution, the average standard deviation in brain age index estimates was then 
used to calculate the probability that a patient’s brain age index is equal to a certain value 𝑦, given that 
their estimate of brain age index is equal to 𝑥. These results are reported as a probability density table. 
To facilitate usability within real world clinical and research contexts, we also calculated the probability 
that a patient’s true underlying brain age is greater than or equal to a certain value 𝑦, given that their 
brain age estimate is equal to 𝑥. These results are presented in the brain age risk lookup table. 
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3. Results 
3.1. Patient Cohort 
Patient characteristics are shown in Table 1. Sleep stage summary values are found in Table 2. 
Our patient cohort was 65% female (𝑛=56), 73% (𝑛=63) of patients had a diagnosis of epilepsy and 61% 
(𝑛 =52) used anti-epileptic drugs during the EMU stay (Table 1).  The cohort had a mean of 5.6 epochs of 
data per patient, a mean age of 42.0 (SD=13.8), and a mean BAI of 12.3 (SD=12.7). Total recording time 
was 5,472 hours, with a sleep efficiency of 0.73 (Table 2). 
Although average BAI for epileptic patients (BAI=13.2, 𝑛=63) was higher than for non-epileptic patients 
(BAI=9.9, 𝑛=23) in our cohort, this difference was not statistically significant (p value = 0.14, one-sided 
two-sample Welch’s t-test). Night-to-night variability (BAI standard deviation) was also not significantly 
different between these two groups (two-sided two-sample t-test, epileptic patients’ BAI standard 
deviation average sd=7.7 vs. non-epileptic patients BAI average sd = 7.7; p = 0.49). 
Table 1. Patient characteristics, medical history, and AED administration. 
Patient Characteristics 
n    86 
Age (mean (SD))    41.97 (13.84) 
Mean BAI (mean (SD))    12.30 (12.68) 
Female Gender (%)    56 (65.1)  
White Race (%)    81 (94.2)  
Medical History 
Epilepsy (%)    63 (73.3)  
Hypertension (%)    35 (40.7)  
Tobacco (%)    20 (23.3)  
Diabetes (%)     8 ( 9.3)  
Substance use (%)     4 ( 4.7)  
AED Administration 
Any AED (%)     55 (64.0)  
Levetiracetam (%)     19 (22.1)  
Lamotrigine (%)     19 (22.1)  
Clonazepam (%)     14 (16.3)  
Gabapentin (%)     16 (18.6)  
Lorazepam (%)      9 (10.5)  
Other (%)     10 (11.6)  
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Table 2. Summary statistics of sleep. 
Sleep Summary 
Total Recording Time (hrs) 5472 
Total Sleep Time (hrs) 3984 
Sleep Efficiency 0.73 
n epochs (mean (SD))  5.6 (3.4) 
Epoch length (mean (SD)) 11.4 (1.5) 
Sleep Stage Totals (hrs (%)) 
N1 599 (10.9) 
N2 2,307 (42.2) 
N3 101 (1.8) 
REM 978 (17.9) 
Awake 1036 (18.9) 
nan 453 (8.3) 
Patient Sleep Stage (hrs (%)) 
N1 1.2 (11.0) 
N2 4.7 (41.8) 
N3 0.2 (1.9) 
REM 2.1 (18.4) 
Awake 2.1 (18.6) 
nan .62 (13.0) 
 
3.2. Brain Age 
Figure 3 shows two brain age estimates for two different patients. Patient 1 (2A and B) has similar brain 
age estimates for both nights, while patient 2 (2C and D) has different brain age estimates for multiple 
nights. Some aspects of night-to-night variability in sleep patterns can be seen in the EEG spectrogram 
shown in this figure. 
 
Figure 3- Example patient epochs and calculated brain ages (BA) for two patients. Patient 1 (left) has a 
stable BA estimate across two nights. Patient 2 (right) has two different BA estimates, with regions of 
increased delta power associated with a younger BA. Each subplot is a power spectrum for the patient 
for brain waves of frequency 0-60. Dark blue indicates low power, while red indicates high power. 
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3.3. Night-to-Night Variability 
The estimated within-patient night-to-night standard deviation in BAI was 7.5 years. Estimates of BAI 
derived by averaging over 2, 3, and 4 nights, had lower estimated standard deviations of 4.7, 3.7, and 
3.0 years, respectively. The standard error of the average of 𝑛 BAI estimates approximately decreases 
according to 1 √𝑛⁄  as 𝑛 increases, as shown in Figure 4, in support of our “signal + noise” model of BAI 
night-to-night variability.  
 
Figure 4- Average standard deviation in BAI for all patients when samples of sizes 1, 2, 3, and 4 nights 
are taken respectively. X axis: number of nights averaged, or n. The dashed line represents the decrease 
in standard error we would expect with increasing sample size (SD/√𝑛). ** represents two outliers with 
BAI = 20 and 30 respectively. 
 
3.4. Effect of Sleep Stages and Patient Covariates on BAI Variability 
Neither the percent of time spent in each sleep stage nor the variability in percent of time spent in each 
sleep stage were significant predictors of night-to-night variability of BAI for any of the variables tested. 
P-values for univariate and multivariate linear regression are provided in Supplementary Tables S1 and 
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S2. This suggests that variation in stage distribution does not significantly contribute to night-to-night 
variability of BAI.  
3.5. Brain Age Risk Lookup Table 
The results showing the probability that a patient’s actual brain age is equal to 𝑦 given that their 
estimated brain age is 𝑥 are shown in the probability density tables of Figure 5. When 𝑛 = 1, we see 
that the probability distribution is relatively flat and diffuse, reflecting relatively high night-to-night 
variability of BAI measurements for a single individual from a single night of sleep. By contrast, for a 
patient whose BAI is averaged over four nights, the probability that the true BAI is equal to their 
estimated BAI (within 0.5 years) is 12.9%, and further calculations show that there is a 50% probability 
that a patient’s average brain age estimate from four nights is within 2.0 years of their actual brain age. 
We also see that the post-measurement probability distribution becomes decidedly more concentrated 
around the estimated value, reflecting the higher signal-to-noise ratio of multi-night BAI estimates.  
The brain age risk lookup tables are also shown in Figure 6. These are similar to the probability density 
tables, except that probabilities shown are the likelihood that a patient’s true brain age is greater than 
or equal to 𝑦 given an estimated brain age of 𝑥. Since increased brain age is viewed as concerning for 
the presence of pathology, this table can be used to calculate a patient’s risk of having an abnormally 
high BAI. 
The blue boxed value in Figure 6c can be interpreted as follows: A typical patient with an estimated BAI 
of 8 when averaging three nights of BAI estimates has a 91% chance that their true BAI is greater than or 
equal to 3. Other values can be interpreted similarly. 
13 
 
 
Figure 5- Table of probability density. The probability that a patient’ true BAI is equal to (±.5years) their 
estimated BAI if the estimate is calculated from a single night, or the average BAI 2, 3 or 4 nights. 
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Figure 6- Table of risk probability that a patient’s true BAI (based on infinite nights of EEG recordings) is 
greater than or equal to their estimated BAI if the estimate is calculated from a single night, or when it is 
averaged from 2, 3 or 4 nights. 
 
 
 
 
 
 
15 
 
4. Discussion 
Building on the idea that BAI may serve as an accessible biomarker of brain aging, our study quantifies 
the accuracy of BAI estimates at the individual level, thus providing guidelines for eventually employing 
such estimates in patient care or clinical trials. We find that the average standard deviation in BAI within 
individual patients (SD) is approximately 7.5 years. Moreover, a simple “signal+noise” model provides a 
good description of the data, with night-to-night variability predictably decreasing as SD/√𝑛 as the 
number of available overnight sleep EEG measurements increases. In particular, averaging over four 
consecutive nights (or four nights within a few days of each other) reduces noise in BAI estimates by 
more than half, to 3.0. At-home sleep monitoring devices, such multi-day sleep measurements are 
increasingly practical. Thus, these findings bring BAI one step closer to being useable as a measure of 
brain health in individual patients, whereas previous work has shown results applicable only at the 
population level.  
Interestingly, our estimate of SD = 7.5 for night-to-night BAI variability within individual patients is close 
to the average standard deviation between patients found in a previous brain age study among healthy 
subjects (SD = 8.5 years) (Sun et al. 2019). These results suggest that in a healthy population (mean BAI 
of 0), much of the interpatient variability is simply due to night-to-night variability in sleep 
microstructure.  
While the main aim of our present study was to measure the night-to-night variability in patient brain 
age, it is interesting that the average BAI in our study is 13 years. We believe there is a simple 
explanation for this. Patients in the EMU are often kept awake late into the night in an attempt to 
provoke seizures, which may result in a relative paucity of N3 sleep. This lower prevalence of epochs 
classified as N3 sleep is normal / typical in older people (Edwards et al. 2010; Varga et al. 2016). Indeed, 
this idea is quantified in the brain age model itself, where the coefficient associated with N3 sleep is 
negative. As measuring night-to-night variability is the aim of this analysis, a shift in the mean BAI is not 
expected to alter the results of this study. Another possible contributing factor to the high brain age in 
our cohort is the high prevalence of epilepsy patients. This explanation would be in agreement with 
recent studies showing that MRI-based BAI is higher in patients with medically refractory epilepsy as 
compared to non-epileptic patients (Pardoe et al. 2017), and another study showing that MRI-based BAI 
was higher in five out of six epileptic categories (all but extra-temporal lobe focal epilepsy) when 
compared to non-epileptic control patients (Sone et al. 2019). Nevertheless, while BAI was higher on 
average for epileptic patients vs. those without an established epilepsy diagnosis, in our data this 
difference was not statistically significant. The relatively small sample size is a possible explanation.  
Night-to-night stability of the BAI is in keeping with other estimates of night-to-night variability/stability 
of sleep physiology. These include EEG patterns using high-density EEG (Massimini et al. 2004), sleep 
EEG data from twins (Hori 1986; Gorgoni et al. 2019), heart rate response to arousal from sleep (Gao et 
al. 2017), performance deficits following sleep deprivation (Kuna et al. 2012), and sleep stability 
assessed by cardiopulmonary coupling (Thomas et al. 2018).  
Our present results provide guidance for how to interpret brain age index values measured for an 
individual in light of prior population studies. Sun et al. previously showed the population-level 
difference between patients with diabetes and those without is 3.5 years, and patients with neurological 
disorders had a BAI that was an average of 4.0 years higher than that of healthy control patients (Sun et 
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al. 2019). Combined with our current results, we see that an individual with a four-night (average) BAI of 
8 years or greater has a 90% chance that their true BAI is at least 4, raising the probability that this 
patient indeed has underlying brain pathology. This information may serve as a warning signal of the 
possible presence of neurodegenerative disease or other chronic diseases that may have secondary 
effects on brain function, warranting further investigation or monitoring.  
There are several limitations in our study. (1) Our cohort is comprised of EMU patients. While EEG 
epochs with epileptiform activity were excluded from the study, 73% of our patient cohort had a clinical 
diagnosis of epilepsy. Furthermore, out-of-home sleep is typically thought to be disrupted, particularly  
during the first night. Therefore, this patient cohort may not represent the general patient population. 
(2) Our analysis assumes a uniform pre-test probability distribution for the brain age index. However, 
since the brain age distribution is unknown population-wide, this assumption seems reasonable, as it 
avoids assuming healthy or sick BAI values. This assumption also supports the overarching goal of the 
algorithm as an accurate biomarker for any patient, whether healthy or sick, without assuming the 
patient’s state beforehand. Nevertheless, future research should investigate whether it is useful to 
create more specific pretest probability distributions for specific populations, e.g., based on gender, race, 
medical symptoms, or other clinical characteristics. (3) Sleep staging was performed algorithmically as 
opposed to being hand-labeled by experts. However, this may be argued as a strength, since it reduces 
between-expert variation in sleep staging as an additional potential source of variation. (4) 61% of 
patients received antiepileptic drugs during their stay at the EMU which may have affected the EEG 
signal and consequently the BAI calculation. 
 
5. Conclusion 
In conclusion, averaging brain ages calculated from multiple nights reduces the effect of night-to-night 
variability, providing a biomarker of brain health interpretable at the level of an individual. We have 
provided figures that can serve as clinical guides in applying EEG-based brain age as a biomarker of brain 
aging.  
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Supplementary Tables 
Table S1. The percent of time spent in each stage was used to predict standard deviation in BAI for each 
patient. 
% Time Univariate Regression p-value Multivariate Regression p-value 
N1 0.23 0.31 
N2 0.61 0.85 
N3 0.8 0.57 
REM 0.14 0.16 
Awake 0.52 0.81 
 
Table S2. The standard deviation in percent of time spent in each stage was used to predict standard 
deviation in BAI for each patient. 
SD % Time Univariate Regression p-value Multivariate Regression p-value 
N1 0.9 0.96 
N2 0.23 0.22 
N3 0.54 0.19 
REM 0.15 0.15 
Awake 0.18 0.5 
 
